INCYTE CORPORATION Income Tax Expense
INCYTE CORPORATION (INCY) reported Income Tax Expense of $40.27 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-04-28
- INCYTE CORPORATION income tax expense (benefit) for the quarter ending 2026-03-31 was $40.27M, a 47.00% decline year-over-year.
- INCYTE CORPORATION income tax expense (benefit) for the quarter ending 2025-12-31 was $90.66M, a 19.42% decline year-over-year.
- INCYTE CORPORATION income tax expense (benefit) for the quarter ending 2025-09-30 was $58.14M, a 16.12% increase year-over-year.
- INCYTE CORPORATION income tax expense (benefit) for the quarter ending 2025-06-30 was $153.01M, a 179.10% increase year-over-year.
- INCYTE CORPORATION income tax expense (benefit) for fiscal 2025 was $377.80M, a 33.02% increase from fiscal 2024.
- INCYTE CORPORATION income tax expense (benefit) for fiscal 2024 was $284.01M, a 20.03% increase from fiscal 2023.
- INCYTE CORPORATION income tax expense (benefit) for fiscal 2023 was $236.62M, a 25.56% increase from fiscal 2022.
- INCYTE CORPORATION income tax expense (benefit) for fiscal 2022 was $188.46M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-03-31 | $40.27M 10-Q · filed 2026-04-28 | $130.93M derived: sum of 2 quarters · filed 2026-04-28 | $189.07M derived: sum of 3 quarters · filed 2026-04-28 | $342.08M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $90.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $148.80M derived: sum of 2 quarters · filed 2026-02-10 | $301.81M derived: sum of 3 quarters · filed 2026-02-10 | $377.80M 10-K · filed 2026-02-10 |
| 2025-09-30 | $58.14M 10-Q · filed 2025-10-28 | $211.15M derived: sum of 2 quarters · filed 2025-10-28 | $287.14M 10-Q · filed 2025-10-28 | $399.65M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $153.01M 10-Q · filed 2025-07-29 | $229.00M 10-Q · filed 2025-07-29 | $341.51M derived: sum of 3 quarters · filed 2026-04-28 | $391.58M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $75.99M 10-Q · filed 2026-04-28 | $188.50M derived: sum of 2 quarters · filed 2026-04-28 | $238.57M derived: sum of 3 quarters · filed 2026-04-28 | $293.39M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $112.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $162.58M derived: sum of 2 quarters · filed 2026-02-10 | $217.40M derived: sum of 3 quarters · filed 2026-02-10 | $284.01M 10-K · filed 2026-02-10 |
| 2024-09-30 | $50.07M 10-Q · filed 2025-10-28 | $104.89M derived: sum of 2 quarters · filed 2025-10-28 | $171.50M 10-Q · filed 2025-10-28 | $241.38M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $54.82M 10-Q · filed 2025-07-29 | $121.44M 10-Q · filed 2025-07-29 | $191.31M derived: sum of 3 quarters · filed 2026-02-10 | $253.84M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $66.61M 10-Q · filed 2025-04-29 | $136.49M derived: sum of 2 quarters · filed 2026-02-10 | $199.02M derived: sum of 3 quarters · filed 2026-02-10 | $273.07M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $69.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $132.41M derived: sum of 2 quarters · filed 2026-02-10 | $206.46M derived: sum of 3 quarters · filed 2026-02-10 | $236.62M 10-K · filed 2026-02-10 |
| 2023-09-30 | $62.53M 10-Q · filed 2024-10-29 | $136.59M derived: sum of 2 quarters · filed 2024-10-29 | $166.74M 10-Q · filed 2024-10-29 | $218.89M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $74.06M 10-Q · filed 2024-07-30 | $104.21M 10-Q · filed 2024-07-30 | $156.36M derived: sum of 3 quarters · filed 2025-02-10 | $192.18M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $30.15M 10-Q · filed 2024-04-30 | $82.31M derived: sum of 2 quarters · filed 2025-02-10 | $118.12M derived: sum of 3 quarters · filed 2025-02-10 | $186.07M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $52.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $87.97M derived: sum of 2 quarters · filed 2025-02-10 | $155.91M derived: sum of 3 quarters · filed 2025-02-10 | $188.46M 10-K · filed 2025-02-10 |
| 2022-09-30 | $35.81M 10-Q · filed 2023-10-31 | $103.76M derived: sum of 2 quarters · filed 2023-10-31 | $136.30M 10-Q · filed 2023-10-31 | -$307.53M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $67.95M 10-Q · filed 2023-08-01 | $100.49M 10-Q · filed 2023-08-01 | -$343.34M derived: sum of 3 quarters · filed 2024-02-13 | -$315.61M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $32.54M 10-Q · filed 2023-05-02 | -$411.29M derived: sum of 2 quarters · filed 2024-02-13 | -$383.56M derived: sum of 3 quarters · filed 2024-02-13 | -$361.38M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$443.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$416.10M derived: sum of 2 quarters · filed 2024-02-13 | -$393.92M derived: sum of 3 quarters · filed 2024-02-13 | -$378.14M 10-K · filed 2024-02-13 |
| 2021-09-30 | $27.73M 10-Q · filed 2022-11-01 | $49.91M derived: sum of 2 quarters · filed 2022-11-01 | $65.69M 10-Q · filed 2022-11-01 | $83.95M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $22.18M 10-Q · filed 2022-08-02 | $37.96M 10-Q · filed 2022-08-02 | $56.22M derived: sum of 3 quarters · filed 2023-02-07 | $67.91M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $15.79M 10-Q · filed 2022-05-03 | $34.04M derived: sum of 2 quarters · filed 2023-02-07 | $45.73M derived: sum of 3 quarters · filed 2023-02-07 | $62.70M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $18.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $29.95M derived: sum of 2 quarters · filed 2023-02-07 | $46.91M derived: sum of 3 quarters · filed 2023-02-07 | $63.48M 10-K · filed 2023-02-07 |
| 2020-09-30 | $11.70M 10-Q · filed 2021-11-02 | $28.66M derived: sum of 2 quarters · filed 2021-11-02 | $45.23M 10-Q · filed 2021-11-02 | $60.23M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $16.97M 10-Q · filed 2021-08-03 | $33.53M 10-Q · filed 2021-08-03 | $48.53M derived: sum of 3 quarters · filed 2022-02-08 | $68.28M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $16.57M 10-Q · filed 2021-05-04 | $31.57M derived: sum of 2 quarters · filed 2022-02-08 | $51.31M derived: sum of 3 quarters · filed 2022-02-08 | $54.67M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $34.75M derived: sum of 2 quarters · filed 2022-02-08 | $38.10M derived: sum of 3 quarters · filed 2022-02-08 | $39.88M 10-K · filed 2022-02-08 |
| 2019-09-30 | $19.75M 10-Q · filed 2020-11-05 | $23.10M derived: sum of 2 quarters · filed 2020-11-05 | $24.89M 10-Q · filed 2020-11-05 | $26.54M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $3.35M 10-Q · filed 2020-08-04 | $5.14M 10-Q · filed 2020-08-04 | $6.79M derived: sum of 3 quarters · filed 2021-02-09 | $8.59M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $1.78M 10-Q · filed 2020-05-05 | $3.44M derived: sum of 2 quarters · filed 2021-02-09 | $5.24M derived: sum of 3 quarters · filed 2021-02-09 | $6.85M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $3.45M derived: sum of 2 quarters · filed 2021-02-09 | $5.07M derived: sum of 3 quarters · filed 2021-02-09 | $5.85M 10-K · filed 2021-02-09 |
| 2018-09-30 | $1.80M 10-Q · filed 2019-10-29 | $3.41M derived: sum of 2 quarters · filed 2019-10-29 | $4.20M 10-Q · filed 2019-10-29 | $5.55M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $1.61M 10-Q · filed 2019-07-30 | $2.40M 10-Q · filed 2019-07-30 | $3.75M derived: sum of 3 quarters · filed 2020-02-13 | $11.05M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $786.00K 10-Q · filed 2019-04-30 | $2.14M derived: sum of 2 quarters · filed 2020-02-13 | $9.44M derived: sum of 3 quarters · filed 2020-02-13 | $12.54M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $8.65M derived: sum of 2 quarters · filed 2020-02-13 | $11.75M derived: sum of 3 quarters · filed 2020-02-13 | $852.00K 10-K · filed 2020-02-13 |
| 2017-09-30 | $7.30M 10-Q · filed 2018-10-30 | $10.40M derived: sum of 2 quarters · filed 2018-10-30 | -$500.00K 10-Q · filed 2018-10-30 | $72.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $3.10M 10-Q · filed 2018-07-31 | -$7.80M 10-Q · filed 2018-07-31 | -$7.23M derived: sum of 3 quarters · filed 2019-02-14 | -$5.80M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$10.90M 10-Q · filed 2018-05-01 | -$10.33M derived: sum of 2 quarters · filed 2019-02-14 | -$8.90M derived: sum of 3 quarters · filed 2019-02-14 | -$8.12M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $2.00M derived: sum of 2 quarters · filed 2019-02-14 | $2.78M derived: sum of 3 quarters · filed 2019-02-14 | $3.18M 10-K · filed 2019-02-14 |
| 2016-09-30 | $1.43M 10-Q · filed 2017-10-31 | $2.21M derived: sum of 2 quarters · filed 2017-10-31 | $2.61M 10-Q · filed 2017-10-31 | $3.12M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $785.00K 10-Q · filed 2017-08-01 | $1.19M 10-Q · filed 2017-08-01 | $1.70M derived: sum of 3 quarters · filed 2018-02-15 | $1.71M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $400.00K 10-Q · filed 2017-05-04 | $912.00K derived: sum of 2 quarters · filed 2018-02-15 | $921.00K derived: sum of 3 quarters · filed 2018-02-15 | $1.06M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $521.00K derived: sum of 2 quarters · filed 2018-02-15 | $657.00K derived: sum of 3 quarters · filed 2018-02-15 | $1.02M 10-K · filed 2018-02-15 |
| 2015-09-30 | $9.00K 10-Q · filed 2016-11-01 | $145.00K derived: sum of 2 quarters · filed 2016-11-01 | $513.00K 10-Q · filed 2016-11-01 | $255.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $136.00K 10-Q · filed 2016-08-09 | $503.00K 10-Q · filed 2016-08-09 | $246.00K derived: sum of 3 quarters · filed 2017-02-14 | $318.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $367.00K 10-Q · filed 2016-05-09 | $110.00K derived: sum of 2 quarters · filed 2017-02-14 | $182.00K derived: sum of 3 quarters · filed 2017-02-14 | $252.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | -$257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$185.00K derived: sum of 2 quarters · filed 2017-02-14 | -$115.00K derived: sum of 3 quarters · filed 2017-02-14 | -$66.00K 10-K · filed 2017-02-14 |
| 2014-09-30 | $72.00K 10-Q · filed 2015-11-03 | $142.00K derived: sum of 2 quarters · filed 2015-11-03 | $191.00K 10-Q · filed 2015-11-03 | $328.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $70.00K 10-Q · filed 2015-08-04 | $119.00K 10-Q · filed 2015-08-04 | $256.00K derived: sum of 3 quarters · filed 2016-02-12 | $305.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $49.00K 10-Q · filed 2015-04-30 | $186.00K derived: sum of 2 quarters · filed 2016-02-12 | $235.00K derived: sum of 3 quarters · filed 2016-02-12 | $306.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $186.00K derived: sum of 2 quarters · filed 2016-02-12 | $257.00K derived: sum of 3 quarters · filed 2016-02-12 | $299.00K 10-K · filed 2016-02-12 |
| 2013-09-30 | $49.00K 10-Q · filed 2014-10-30 | $120.00K derived: sum of 2 quarters · filed 2014-10-30 | $162.00K 10-Q · filed 2014-10-30 | $244.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $71.00K 10-Q · filed 2014-07-31 | $113.00K 10-Q · filed 2014-07-31 | $195.00K derived: sum of 3 quarters · filed 2015-02-17 | $221.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $43.00K 10-Q · filed 2014-05-01 | $124.00K derived: sum of 2 quarters · filed 2015-02-17 | $150.00K derived: sum of 3 quarters · filed 2015-02-17 | $217.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $107.00K derived: sum of 2 quarters · filed 2015-02-17 | $174.00K derived: sum of 3 quarters · filed 2015-02-17 | $174.00K 10-K · filed 2015-02-17 |
| 2012-09-30 | $26.00K 10-Q · filed 2013-10-31 | $93.00K derived: sum of 2 quarters · filed 2013-10-31 | $93.00K 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $67.00K 10-Q · filed 2013-08-01 | $67.00K 10-Q · filed 2013-08-01 | ||
| 2010-09-30 | -$658.00K 10-Q · filed 2011-10-27 | -$327.00K derived: sum of 2 quarters · filed 2011-10-27 | $0.00 derived: sum of 3 quarters · filed 2011-10-27 | |
| 2010-06-30 | $331.00K 10-Q · filed 2011-07-28 | $658.00K 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $327.00K 10-Q · filed 2011-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |